• Z-LEHD-FMK: Irreversible Caspase-9 Inhibitor for Apoptosis A

  2026-07-20

  Z-LEHD-FMK stands out as a selective, irreversible caspase-9 inhibitor, enabling precise investigation of mitochondrial apoptosis in both cancer and neuroprotection models. This article delivers protocol enhancements, troubleshooting tactics, and cross-study insights to maximize data reliability in apoptosis assays.

• PEDV Exploits IMPDH-Dependent Nucleotide Biosynthesis for Re

  2026-07-20

  This study demonstrates that porcine epidemic diarrhea virus (PEDV) manipulates host IMPDH-dependent guanine nucleotide biosynthesis to enable efficient viral replication. Both genetic and pharmacological inhibition of IMPDH, including with Merimepodib (VX-497), markedly impairs viral replication, establishing IMPDH as a strategic host-targeted antiviral vulnerability.

• CD98hc Orchestrates CNS Angiogenesis via Integrin–FAK Pathwa

  2026-07-19

  This study uncovers the pivotal role of CD98 heavy chain (CD98hc) in orchestrating central nervous system (CNS) angiogenesis and maintaining blood–brain barrier (BBB) integrity by locally regulating the systemic integrin–FAK pathway. The findings redefine tissue-specific vascular signaling in the CNS, providing a mechanistic basis for targeted therapies in cerebrovascular disorders.

• Tamoxifen in Research: Applied Protocols and Troubleshooting

  2026-07-18

  Tamoxifen stands out as a versatile selective estrogen receptor modulator for both gene knockout and cancer research. This guide details hands-on workflows, advanced applications, and optimization strategies, using recent peer-reviewed studies and real-world lab insights.

• Multi-Omics Mapping of ARID1A-Driven Resistance in Melanoma

  2026-07-17

  This study introduces an integrative multi-omics framework to define drug response networks and ARID1A-dependent resistance mechanisms in BRAF-mutant melanoma. Key findings reveal how ARID1A loss rewires signaling, sustaining MAPK pathway activity and immune evasion, and highlight critical nodes for targeting resistance.

• Clodronate Liposomes: Precision In Vivo Macrophage Depletion

  2026-07-17

  Clodronate Liposomes enable targeted, reproducible in vivo macrophage depletion, providing a transformative tool for dissecting immune cell function in disease models. This guide details protocol enhancements, advanced troubleshooting, and evidence-based insights to maximize the impact of liposome-encapsulated clodronate in immunotherapy and tumor microenvironment research.

• Targeted SPP1 Inhibition in Tumor Macrophages Reduces Tumor

  2026-07-16

  Kartal et al. introduce a novel nanoformulation that selectively down-regulates SPP1 expression in tumor-associated macrophages (TAM), yielding significant tumor size reduction in murine models. This work provides a new paradigm for targeting immunosuppressive TAM phenotypes and lays the groundwork for advancing combinatorial small molecule strategies in the tumor microenvironment.

• ML133 HCl: Precision Potassium Channel Inhibitor Workflows

  2026-07-16

  ML133 HCl empowers researchers with selective inhibition of Kir2.1, enabling high-fidelity analysis of potassium ion transport in cardiovascular and pulmonary models. Its robust specificity and solution compatibility unlock advanced protocols for dissecting pulmonary artery smooth muscle cell behavior.

• Sulfo-NHS-Biotin: Precision Cell Surface Labeling in Protein

  2026-07-15

  Sulfo-NHS-Biotin stands out as a water-soluble, amine-reactive biotinylation reagent optimized for high-fidelity cell surface protein labeling. Its superior selectivity and aqueous compatibility support robust affinity workflows and advanced proteomic applications.

• Vidarabine Monohydrate: Antiviral Mechanisms & Research Util

  2026-07-15

  Vidarabine monohydrate, a potent nucleoside analog, is widely used as an antiviral research compound for its precise inhibition of viral DNA synthesis. The compound's high purity and DMSO solubility make it a benchmark tool in studying DNA replication interference, especially in herpes simplex virus research. This article details its validated mechanisms, protocol parameters, and critical limitations for laboratory use.

• Vaginal Bacterial Extracellular Vesicles Traverse Mucus Barr

  2026-07-14

  This study demonstrates that extracellular vesicles (bEVs) from vaginal bacteria can diffuse through human cervicovaginal mucus, unlike whole bacteria, enabling direct microbe-host signaling in the female reproductive tract. These findings shed light on novel mechanisms by which vaginal microbiota influence gynecologic and obstetric outcomes, and offer new perspectives for therapeutic strategies targeting dysbiosis.

• Toremifene in Prostate Cancer: Mechanistic Insights and Assa

  2026-07-14

  Explore how Toremifene, a selective estrogen-receptor modulator, advances prostate cancer research through deep mechanistic insight and innovative in vitro assay optimization. This article uniquely bridges molecular signaling with practical protocol guidance for hormone-responsive cancer studies.

• FCCP in Mitochondrial Biology: Advanced Workflows & Troubles

  2026-07-13

  FCCP, or carbonyl cyanide p-trifluoromethoxyphenylhydrazone, is the gold-standard mitochondrial uncoupler empowering precise interrogation of oxidative phosphorylation, HIF pathway inhibition, and metabolic regulation. This guide delivers actionable protocols, troubleshooting strategies, and cross-platform insights for researchers seeking reproducibility and depth in mitochondrial biology research.

• Pharmacokinetic Variability of CSBTA in MASH: Mechanisms and

  2026-07-13

  This study elucidates how metabolic disease states, specifically HFHCD-induced MASH in mice, alter the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA). The findings highlight the influence of liver pathology on drug exposure, transporter and enzyme regulation, and support rational dosing for MASLD/MASH therapies.

• ECL Western Blotting Substrate: Technical Workflow and QC Gu

  2026-07-12

  The ECL Western Blotting Substrate (SKU K2187) addresses the need for sensitive, nonradioactive chemiluminescent detection of HRP in Western blot assays, providing clear signal with minimal background. It is designed for protein detection workflows in molecular and cancer biology, but is not suitable for fluorescent or radioisotopic assay formats.

724 records 13/49 page Previous Next First page 上5页 1112131415 下5页 Last page